Literature DB >> 20028659

Proteases in MHC class I presentation and cross-presentation.

Kenneth L Rock1, Diego J Farfán-Arribas, Lianjun Shen.   

Abstract

Cells that have mutated their genes or are virally infected are a potential threat to a host. Consequently, the immune system has evolved mechanisms for CD8 T lymphocytes to identify such cells and eliminate them. The generation of CD8 T cell responses occurs in two phases, both of which critically involve the process of Ag presentation. In the first phase, sentinel cells gather Ags present in tissues and then present them to naive CD8 T cells in ways that stimulate their maturation into effectors. In the second phase, these effector cells seek out and eliminate the pathological cells. The abnormal cells are identified through their presentation of immunogenic Ags that they are producing. The Ag presentation mechanisms used by the sentinel cells can be different from those in other cells. This article will review these mechanisms with a focus in each case on how antigenic peptides are generated for presentation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20028659      PMCID: PMC3094101          DOI: 10.4049/jimmunol.0903399

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

1.  Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.

Authors:  X Y Mo; P Cascio; K Lemerise; A L Goldberg; K Rock
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

2.  Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement.

Authors:  Jan Diekmann; Eleni Adamopoulou; Olaf Beck; Georg Rauser; Sarah Lurati; Stefan Tenzer; Hermann Einsele; Hans-Georg Rammensee; Hansjörg Schild; Max S Topp
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

3.  Direct antigen presentation and gap junction mediated cross-presentation during apoptosis.

Authors:  Baoxu Pang; Joost Neijssen; Xiaohang Qiao; Lennert Janssen; Hans Janssen; Christoph Lippuner; Jacques Neefjes
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

4.  Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis.

Authors:  N Tanahashi; Y Murakami; Y Minami; N Shimbara; K B Hendil; K Tanaka
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

5.  IRAP identifies an endosomal compartment required for MHC class I cross-presentation.

Authors:  Loredana Saveanu; Oliver Carroll; Mirjana Weimershaus; Pierre Guermonprez; Elke Firat; Vivian Lindo; Fiona Greer; Jean Davoust; Roland Kratzer; Susanna R Keller; Gabriele Niedermann; Peter van Endert
Journal:  Science       Date:  2009-06-04       Impact factor: 47.728

6.  Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis.

Authors:  W P Maksymowych; R D Inman; D D Gladman; J P Reeve; A Pope; P Rahman
Journal:  Arthritis Rheum       Date:  2009-05

7.  Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.

Authors:  Masahiro Kawahara; Ian A York; Arron Hearn; Diego Farfan; Kenneth L Rock
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum.

Authors:  Arron Hearn; Ian A York; Kenneth L Rock
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

9.  Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis.

Authors:  Florence W L Tsui; Nigil Haroon; John D Reveille; Proton Rahman; Basil Chiu; Hing Wo Tsui; Robert D Inman
Journal:  Ann Rheum Dis       Date:  2009-05-10       Impact factor: 19.103

10.  Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation.

Authors:  Roger Belizaire; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-25       Impact factor: 11.205

View more
  44 in total

Review 1.  Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come.

Authors:  Ayesha Murshid; Jianlin Gong; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Expert Rev Vaccines       Date:  2011-11       Impact factor: 5.217

Review 2.  Protease signalling: the cutting edge.

Authors:  Boris Turk; Dušan Turk; Vito Turk
Journal:  EMBO J       Date:  2012-02-24       Impact factor: 11.598

Review 3.  Generation of MHC class I ligands in the secretory and vesicular pathways.

Authors:  Margarita Del Val; Salvador Iborra; Manuel Ramos; Silvia Lázaro
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

4.  Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.

Authors:  Brian P Dolan; Lily Li; Charles A Veltri; Chris M Ireland; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

5.  Central and overlapping role of Cathepsin B and inflammasome adaptor ASC in antigen presenting function of human dendritic cells.

Authors:  Xiuyang Guo; Kavita M Dhodapkar
Journal:  Hum Immunol       Date:  2012-06-22       Impact factor: 2.850

6.  Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.

Authors:  Yosuke Shionoya; Takayuki Kanaseki; Sho Miyamoto; Serina Tokita; Ayumi Hongo; Yasuhiro Kikuchi; Vitaly Kochin; Kazue Watanabe; Ryota Horibe; Hiroshi Saijo; Tomohide Tsukahara; Yoshihiko Hirohashi; Hiroki Takahashi; Noriyuki Sato; Toshihiko Torigoe
Journal:  Oncoimmunology       Date:  2017-01-03       Impact factor: 8.110

7.  Production of an antigenic peptide by insulin-degrading enzyme.

Authors:  Nicolas Parmentier; Vincent Stroobant; Didier Colau; Philippe de Diesbach; Sandra Morel; Jacques Chapiro; Peter van Endert; Benoît J Van den Eynde
Journal:  Nat Immunol       Date:  2010-04-04       Impact factor: 25.606

8.  Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.

Authors:  Paul K Ziegler; Julia Bollrath; Charles K Pallangyo; Takaji Matsutani; Özge Canli; Tiago De Oliveira; Michaela A Diamanti; Nina Müller; Jaba Gamrekelashvili; Tracy Putoczki; David Horst; Arun K Mankan; Meryem G Öner; Susanna Müller; Josef Müller-Höcker; Thomas Kirchner; Julia Slotta-Huspenina; M Mark Taketo; Thomas Reinheckel; Stefan Dröse; Andrew C Larner; Winfried S Wels; Matthias Ernst; Tim F Greten; Melek C Arkan; Thomas Korn; Dagmar Wirth; Florian R Greten
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

Review 9.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

10.  Immune regulation and evasion of Mammalian host cell immunity during viral infection.

Authors:  B M Pratheek; Soham Saha; Prasanta K Maiti; Soma Chattopadhyay; Subhasis Chattopadhyay
Journal:  Indian J Virol       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.